EP Patent

EP4267203A1 — A cartridge for mixing a phospholipid composition intended for intracorporeal use

Assigned to Solstice Pharmaceuticals BV · Expires 2023-11-01 · 3y expired

What this patent protects

The present invention is related to a cartridge. More in particular, the present invention relates to a cartridge by which a phospholipid composition, held in the cartridge can be mixed, within the cartridge, with a further liquid held in the cartridge or with a pressurized gas. …

USPTO Abstract

The present invention is related to a cartridge. More in particular, the present invention relates to a cartridge by which a phospholipid composition, held in the cartridge can be mixed, within the cartridge, with a further liquid held in the cartridge or with a pressurized gas. The present invention further relates to a cartridge system comprising such a cartridge and a device in which the cartridge can be releasably inserted, wherein the device is configured for providing pressurized gas(ses) to be used as propellant(s) for moving the liquid(s) inside the cartridge for the purpose of mixing the liquid(s), and/or to be used as gas to be mixed.

Drugs covered by this patent

Patent Metadata

Patent number
EP4267203A1
Jurisdiction
EP
Classification
Expires
2023-11-01
Drug substance claim
No
Drug product claim
No
Assignee
Solstice Pharmaceuticals BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.